Schedule 13D ownership disclosure

Xenetic Biosciences, Inc.

Security class unavailable

Event date: 2016-11-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
531,863
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001662252-16-000267
Form type
SC 13D
Filer
Maguire Michael Scott
CIK
CIK 1690490
Filed
Nov 22, 2016
Reporting period
Nov 01, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub